$RLFTF RELIEF ANNOUNCES NOTICE OF EXTRAORDINARY G
Post# of 653
Geneva, Switzerland, November 23, 2020 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company" , a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today gives notice of an Extraordinary General Meeting (EGM) of shareholders to be held on December 17, 2020. (cont'd)
https://relieftherapeutics.com/newsblog/relie...holding-ag